AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Biogen, Elan Dive On Withdrawal
1 Biogen fell 43% and Elan 70% on huge volume after voluntarily suspending sales of promising multiple sclerosis drug Tysabri due to a patient death. The firms hope to have it back on the market within 6 months. It's the latest black eye for the FDA, which gave Tysabri a fast-track approval in Nov. Rival MS drug makers Teva and Serono both jumped on the news. More on this page
Lebanon Gov't Quits Amid Unrest
2Lebanon's prime minister and his Cabinet resigned as thousands of demonstrators in Beirut protested Syria's grip on the nation. Anger against Syria, which has 14,000 troops in the nation, ignited after a former PM and Syrian critic was assassinated Feb. 14. Pressure was mounting on pro-Syrian President Emile Lahoud. More on this page
Iraq Car Bombing Deadliest Yet
3A suicide bomber blew up an explosives-packed car near a line of police recruits across from a crowded market south of Baghdad, killing 125 and injuring 130. It was the deadliest attack in Iraq since Saddam's fall in April '03. The blast targeted recruits waiting to take an eye test, but many of the dead were shoppers at a nearby market.
Inflation Worries Smack Stocks